The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
